Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
10th International Lung Cancer Congress
The Fairmont Orchid
Kohala Coast, HI
June 17-20, 2009
Wednesday, Jun 17, 2009
| 6:30 am | Continental Breakfast and Registration |
| 7:00 am | Welcome and Introductions |
| 7:05 am | Presession Survey |
| Early-Stage NSCLC | |
| 7:10 am | Neoadjuvant Chemotherapy Joan Hoff Schiller |
| 7:25 am | Question-and-Answer Session |
| 7:30 am | Adjuvant Therapy for NSCLC Heather Wakelee |
| 7:45 am | Question-and-Answer Session |
| 7:50 am | Debate: Stage vs. Molecular Markers in Stage IIA NSCLC Markers: Giorgio Scagliotti Stage: Kemp H. Kernstine |
| 8:05 am | Question-and-Answer Session |
| 8:10 am | Debate: Radiation Therapy vs. Surgery in Early-Stage NSCLC Radiation: Walter Curran, Jr Surgery: David M. Jablons |
| 8:25 am | Question-and-Answer Session |
| 8:30 am | When Are Sublobar Resections Appropriate? Stephen Swisher |
| 8:45 am | Question-and-Answer Session |
| 8:50 am | Case-Based Panel Discussion |
| 9:10 am | Break |
| 9:25 am | Panel Discussion: IASLC Staging Project Harvey I. Pass, Paul Baas, David Gandara, Hak Choy |
| Keynote Lecture | |
| 9:45 am | BATTLE Program for Personalized Medicine Roy Herbst |
| 10:05 am | Question-and-Answer Session |
| Angiogenesis Inhibition | |
| 10:10 am | Overview of Angiogenesis Inhibition Alan Sandler |
| 10:25 am | Question-and-Answer Session |
| 10:30 am | Combination Regimens to Inhibit Multiple Signaling Pathways Glenwood Goss |
| 10:45 am | Question-and-Answer Session |
| 10:50 am | Managing Toxicities of Antiangiogenic Agents: Practical Advice for the Clinic Karen Kelly |
| 11:05 am | Question-and-Answer Session |
| 11:10 am | Postsession Survey |
| 11:15 am | Case-Based Panel Discussion |
| 11:35 am | Poster Discussion 1 H. Jack West |
| 11:55 am | Adjourn |
| Workshop 1 | |
| 4:00 pm-6:00 pm | The Next Generation of Targeted Agents in Lung Cancer |
| Overview Paul A. Bunn, Jr. |
|
| P13K/Akt Inhibitors Roy Herbst |
|
| Apoptosis Inducers-Extrinsic Karen Kelly |
|
| Apoptosis Inducers-Intrinsic Primo N. Lara, Jr |
|
| FGF Inhibitors TBA |
|
| c-Met Inhibitors Román Pérez-Soler |
|
| Hedgehog Inhibitors David Gandara |
|
| Hsp90 Inhibitors H. Jack West |
|
| Roundtable Discussion |
|
| 6:30 pm-7:30 pm | Welcome Reception |
Educational Grants
An educational grant for this activity was provided by:
- Bristol-Myers Squibb/ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Millennium Pharmaceuticals
- sanofi-aventis U.S.
- The Bonnie J. Addario Lung Cancer Foundation